-
1.
公开(公告)号:US20120172422A1
公开(公告)日:2012-07-05
申请号:US13418613
申请日:2012-03-13
申请人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
发明人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
IPC分类号: A61K31/381 , A61P25/18 , A61P25/04 , A61P25/00
CPC分类号: A61K38/05 , A61K47/54 , A61K47/542 , A61K47/555 , C07C237/12 , C07C2602/18 , C07D333/78 , C07K5/06026
摘要: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
摘要翻译: 本发明涉及合成兴奋性氨基酸前药及其制备方法。 本发明进一步涉及使用和药物组合物的方法,其包含用于治疗神经障碍和精神障碍的化合物。
-
公开(公告)号:US20110207672A1
公开(公告)日:2011-08-25
申请号:US13100642
申请日:2011-05-04
申请人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
发明人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
CPC分类号: A61K38/05 , A61K47/54 , A61K47/542 , A61K47/555 , C07C237/12 , C07C2602/18 , C07D333/78 , C07K5/06026
摘要: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
摘要翻译: 本发明涉及合成兴奋性氨基酸前药及其制备方法。 本发明进一步涉及使用和药物组合物的方法,所述药物组合物包含用于治疗神经障碍和精神障碍的化合物。
-
公开(公告)号:US20100113579A1
公开(公告)日:2010-05-06
申请号:US12688074
申请日:2010-01-15
申请人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
发明人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
IPC分类号: A61K31/381 , A61P25/00 , A61P25/28 , A61P25/16 , A61P25/06
CPC分类号: A61K38/05 , A61K47/54 , A61K47/542 , A61K47/555 , C07C237/12 , C07C2602/18 , C07D333/78 , C07K5/06026
摘要: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
摘要翻译: 本发明涉及合成兴奋性氨基酸前药及其制备方法。 本发明进一步涉及使用和药物组合物的方法,其包含用于治疗神经障碍和精神障碍的化合物。
-
公开(公告)号:US20080182889A1
公开(公告)日:2008-07-31
申请号:US12059112
申请日:2008-03-31
申请人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
发明人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Jaime Gonzalo Blanco-Urgoiti , Ivan Collado Cano
IPC分类号: A61K31/40 , C07D333/50 , A61K31/381 , A61P25/00 , C07D207/00
CPC分类号: A61K38/05 , A61K47/54 , A61K47/542 , A61K47/555 , C07C237/12 , C07C2602/18 , C07D333/78 , C07K5/06026
摘要: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
摘要翻译: 本发明涉及合成兴奋性氨基酸前药及其制备方法。 本发明进一步涉及使用和药物组合物的方法,所述药物组合物包含用于治疗神经障碍和精神障碍的化合物。
-
公开(公告)号:US07964632B2
公开(公告)日:2011-06-21
申请号:US12688074
申请日:2010-01-15
申请人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Ivan Collado Caño , Jaime Gonzalo Blanco-Urgoiti
发明人: Eric David Moher , James Allen Monn , Concepcion Pedregal-Tercero , Ivan Collado Caño , Jaime Gonzalo Blanco-Urgoiti
IPC分类号: A61K31/38
CPC分类号: A61K38/05 , A61K47/54 , A61K47/542 , A61K47/555 , C07C237/12 , C07C2602/18 , C07D333/78 , C07K5/06026
摘要: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
摘要翻译: 本发明涉及合成兴奋性氨基酸前药及其制备方法。 本发明进一步涉及使用和药物组合物的方法,其包含用于治疗神经障碍和精神障碍的化合物。
-
-
-
-